JRI Orthopaedics UK General Manager Alistair Wheatley
JRI Orthopaedics had a chance to showcase its healthcare solutions during a special UK Government trade mission to India in celebration of the NHS’ 70th birthday.
The four-day trade mission was led by Sir Malcolm Grant, chairman of NHS England, CEO of NHS Digital Sarah Wilkinson, and the Minister of State for Trade and Export Promotion Baroness Fairhead.
Sheffield-based JRI was the only orthopaedics company invited to the three-city mission organized by the Department for International Trade, which included a Royal reception.
The firm’s UK general manager Alistair Wheatley said: “It was a very interesting and useful mission with some excellent contacts made.
“JRI Orthopaedics has a long history of innovation, manufacturing excellence, supporting cutting-edge research and working in partnership with the NHS to deliver solutions that bring about real efficiencies and patient benefits.
“India’s healthcare market is estimated to grow to $280 billion by 2020. With its recent commitment to developing 100 smart cities across the country, demand for innovative healthcare solutions in the Indian healthcare system has never been higher.”
Delegates from NHS Trusts and healthcare companies visited New Dehli, Mumbai and Hyderabad to hear from and meet senior managers from Indian hospitals, medical institutes, colleges and business.
There was also a reception for HRH Prince Edward, Earl of Wessex.
JRI Orthopaedics is based at its manufacturing facility at Chapeltown and has world-class expertise in the design, development and manufacture of orthopaedic implants and surgical instruments.
It was the first company in world orthopaedics to produce a hip implant with a Hydroxyapatite coating enabling a biological bond with the patient’s bone and so the prospect of a hip for life.
JRI Orthopaedics is currently expanding its product portfolio and orthopaedic systems in a bid to streamline the delivery of the best solutions for joint reconstruction, repair and regeneration.
Uniquely, the company is wholly owned by the charity Orthopaedic Research UK (ORUK) and has donated millions to fund world-class research into bone and joint disease.